Harlan Robins spent years as the co-founder and chief scientific officer of Adaptive Biotechnologies, helping build massive datasets to decode… Read More ...
Ying Huang is now running K2 Therapeutics, which has licensed multiple prospects from China-based biotechs and is searching ...
Infinimmune, a California startup, is developing treatments it claims might last longer and be more effective than existing atopic dermatitis medications.
By all rights, Felix Wong and his company should be in Massachusetts. Wong, 33, was born in Quincy, graduated from Braintree High School, and spent a decade living in Cambridge, where he earned two ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal lands another ...
The 6 startups tackle inflammatory disease, cancer, cardiovascular disease, neurological disorders and AI-enabled digital health.
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — A group of European venture ...
Biotech’s old risk-sharing model is breaking down, forcing academia, investors, pharma, and healthcare systems to collaborate ...
That wasn't always Ehrhardt's focus. When he and co-founders Sandeep Singh and Nikki Arora Singh launched the company in 2023, the responsibilities of each team member were broad and varied. "In the ...
The puppies represent a key first step towards addressing canine allergenicity and mark potentially a significant advance in ...
UC Santa Cruz deepens industry engagement to underscore its vital role in contributing basic research and tomorrow’s talent, convening its first international RNA biotech conference on August 18 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results